STERIS plc (NYSE:STE) Shares Bought by Bellevue Group AG

Bellevue Group AG lifted its holdings in STERIS plc (NYSE:STE - Free Report) by 20.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 109,887 shares of the medical equipment provider's stock after purchasing an additional 18,605 shares during the period. Bellevue Group AG owned about 0.11% of STERIS worth $22,588,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Franklin Resources Inc. grew its position in STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock worth $191,370,000 after buying an additional 529,308 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of STERIS by 30.8% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider's stock worth $2,275,000 after acquiring an additional 2,583 shares during the last quarter. Merit Financial Group LLC acquired a new stake in shares of STERIS during the fourth quarter worth $260,000. Blue Trust Inc. lifted its holdings in shares of STERIS by 19.9% during the fourth quarter. Blue Trust Inc. now owns 1,128 shares of the medical equipment provider's stock valued at $232,000 after purchasing an additional 187 shares during the last quarter. Finally, Entropy Technologies LP acquired a new position in shares of STERIS in the 4th quarter valued at $924,000. 94.69% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Piper Sandler upped their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Stephens restated an "overweight" rating and issued a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a research report on Monday, April 7th. Finally, JMP Securities restated a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $258.75.

STERIS Stock Up 1.1 %

STERIS stock opened at $224.71 on Friday. STERIS plc has a twelve month low of $200.98 and a twelve month high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The firm has a market cap of $22.08 billion, a PE ratio of 47.71 and a beta of 0.87. The firm's 50 day moving average price is $223.11 and its two-hundred day moving average price is $218.81.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, research analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.